XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Property and Equipment, net
3 Months Ended
Mar. 31, 2022
Property and Equipment, net  
Property and Equipment, net

Note 8.    Property and equipment, net

Property and equipment, net consists of the following (in thousands):

March 31,

December 31,

    

2022

    

2021

 

Office equipment

    

$

22,409

$

22,554

Laboratory equipment

107,206

    

 

105,040

Computer equipment

 

85,328

 

79,871

Land

10,435

10,494

Building and leasehold improvements

435,770

434,321

Operating lease right-of-use assets

26,540

27,308

Construction in progress

 

227,340

 

220,052

 

915,028

 

899,640

Less accumulated depreciation and amortization

 

(185,811)

 

(175,720)

Property and equipment, net

$

729,217

$

723,920

In March 2017, we acquired additional adjacent buildings to our global headquarters in Wilmington, Delaware and in 2019, began demolition of these buildings and construction of a new laboratory and office building totaling approximately 200,000 square feet. The certificate of occupancy was received in December 2021 and we capitalized approximately $158.2 million in building and office equipment that was previously included in construction in progress as of December 31, 2021.

In February 2018, we signed an agreement to rent a building in Morges, Switzerland for an initial term of 15 years plus one year of free rent, with multiple options to extend for an additional 20 years. The building serves as our new European headquarters and consists of approximately 100,000 square feet of office space. This building allowed for consolidation of our European operations that were located in Geneva and Lausanne, Switzerland. In June 2019, we obtained control of the Morges building to begin our construction activity, which was completed in 2020. At that time, we determined the lease to be a finance lease and recorded a lease liability of $31.1 million and a finance lease right-of-use asset of $29.1 million, net of a lease incentive from our landlord of $2.0 million. We have capitalized approximately $19.5 million in leasehold improvements as of March 31, 2022 relating to Morges.

In July 2018, we signed an agreement to purchase land located in Yverdon, Switzerland. The land was purchased, in cash, for approximately $4.8 million. Upon this parcel, we are constructing a large molecule production facility. Construction activity commenced in July 2018, and as of March 31, 2022, we have capitalized approximately $198.9 million in costs for construction, ground preparation and architectural and engineering studies. Inspection from competent authorities was finalized in March 2022, and we currently expect the facility to be GMP approved in the second half of 2022.